Osimertinib (mesylate) - HY-15772A
Nur noch %1 verfügbar
Catalog #
HY-15772A
Ab
62,00 €
Osimertinib mesylate (AZD9291 mesylate) is a covalent, orally active, irreversible, and mutant-selective EGFR inhibitor with an apparent IC50 of 12 nM against L858R and 1 nM against L858R/T790M. Osimertinib overcomes T790M-mediated resistance to EGFR inhibitors in lung cancer[1].
| Datasheet URL | http://file.medchemexpress.com/batch_PDF/HY-15772A/Osimertinib-mesylate-DataSheet-MedChemExpress.pdf |
|---|---|
| Shipping | Room Temperature |
| Application | Cancer-Kinase/protease |
| Alternative Names | AZD-9291 (mesylate); Mereletinib (mesylate) |
| CAS | 1421373-66-1 |
| Storage | 4°C (Powder, sealed storage, away from moisture) |
| MWT | 595.71 |
| Solubility | DMSO : 11.67 mg/mL (ultrasonic;warming;heat to 60°C) |
| Clinical Information | Launched |
| Target | EGFR |
| Application: | Cancer-Kinase/protease |
|---|